Reference

·

Supporting source

Surviving licensed dispensary share after rollback

~45-50% of 2023 peak

As of2023 peak to mid-2025·Sources3·Supporting

Approximately 45-50% of the late-2023 peak licensed-dispensary stock had survived through mid-2025 following the 2024 recriminalisation per MoPH DTAM register tracking and industry-association estimates (Thai Cannabis Future Network, Thai Industrial Hemp Trade Association). The surviving cohort tilts toward established Bangkok and Chiang Mai operators with FDA-compliant pharmacy-style formats, medical-prescription workflow capacity, and diversified revenue (CBD wellness, food and beverage extracts, hemp-fibre adjacencies). Tourist-strip cannabis storefronts in Khao San, Patong, and Pattaya bore the brunt of closures. The surviving population is the addressable base for any future federal-licensing or medical-tier consolidation play.

Figure in context

Approximately 45-50% of the late-2023 peak licensed-dispensary stock had survived through mid-2025 following the 2024 recriminalisation per MoPH DTAM register tracking and industry-association estimates (Thai Cannabis Future Network, Thai Industrial Hemp Trade Association). The surviving cohort tilts toward established Bangkok and Chiang Mai operators with FDA-compliant pharmacy-style formats, medical-prescription workflow capacity, and diversified revenue (CBD wellness, food and beverage extracts, hemp-fibre adjacencies). Tourist-strip cannabis storefronts in Khao San, Patong, and Pattaya bore the brunt of closures. The surviving population is the addressable base for any future federal-licensing or medical-tier consolidation play.

Approximately 45-50% of the late-2023 peak licensed-dispensary stock had survived through mid-2025 following the 2024 recriminalisation per MoPH DTAM register tracking and industry-association estimates (Thai Cannabis Future Network, Thai Industrial Hemp Trade Association). The surviving cohort tilts toward established Bangkok and Chiang Mai operators with FDA-compliant pharmacy-style formats, medical-prescription workflow capacity, and diversified revenue (CBD wellness, food and beverage extracts, hemp-fibre adjacencies). Tourist-strip cannabis storefronts in Khao San, Patong, and Pattaya bore the brunt of closures. The surviving population is the addressable base for any future federal-licensing or medical-tier consolidation play.

Time scope

2023 peak to mid-2025

Source basis

Supporting source

Interpretation notes

What this tells you

Approximately 45-50% of the late-2023 peak licensed-dispensary stock had survived through mid-2025 following the 2024 recriminalisation per MoPH DTAM register tracking and industry-association estimates (Thai Cannabis Future Network, Thai Industrial Hemp Trade Association). The surviving cohort tilts toward established Bangkok and Chiang Mai operators with FDA-compliant pharmacy-style formats, medical-prescription workflow capacity, and diversified revenue (CBD wellness, food and beverage extracts, hemp-fibre adjacencies). Tourist-strip cannabis storefronts in Khao San, Patong, and Pattaya bore the brunt of closures. The surviving population is the addressable base for any future federal-licensing or medical-tier consolidation play.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

Report context

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

Surviving licensed dispensary share after rollback · Insight